NYSE: WK
WORKIVA INCCIK 0001445305 · SIC 7372 · Prepackaged Software
Mid
Revenue $885M
Assets $1.4B
as of Aug 30, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (SAIC 10-Q) is open in full — no account needed.
8-K
Filed Aug 4, 2026
· Period ending Aug 4, 2026
Summary not yet generated.
10-Q
Filed Aug 4, 2026
· Period ending Jun 30, 2026
Workiva swings to profitability with $13.4M Q2 net income; new SEC/EU regulatory risks disclosed
5 material changes detected. Sign up free to read the summary.
Partner
Trade WK commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Jun 2, 2026
· Period ending May 28, 2026
Workiva shareholders approve 3.9M share increase to equity compensation plan
4 material changes detected. Sign up free to read the summary.
8-K
Filed May 5, 2026
· Period ending May 5, 2026
Workiva announces Q1 2026 financial results
1 material change detected. Sign up free to read the summary.
8-K
Filed May 5, 2026
· Period ending Apr 30, 2026
Red flag
Workiva switches auditors from Ernst & Young to Grant Thornton for fiscal 2026
4 material changes detected. Sign up free to read the summary.
10-Q
Filed May 5, 2026
· Period ending Mar 31, 2026
revenue $247.3M, net income $19.0M. Workiva swings to profit in Q1 2026; EU sustainability rule changes slow adoption
5 material changes detected. Sign up free to read the summary.
10-K
Filed Feb 19, 2026
· Period ending Dec 31, 2025
Summary not yet generated.
10-Q
Filed Nov 5, 2025
· Period ending Sep 30, 2025
Summary not yet generated.
10-Q
Filed Jul 31, 2025
· Period ending Jun 30, 2025
Summary not yet generated.
10-Q
Filed May 1, 2025
· Period ending Mar 31, 2025
Summary not yet generated.
10-K
Filed Feb 25, 2025
· Period ending Dec 31, 2024
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 4, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
(in thousands, except share and per share amounts)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | ||||
| Subscription and support | 236,302 | 198,223 | 461,657 | 383,735 |
| Professional services | 18,988 | 16,964 | 40,939 | 37,732 |
| Total revenue | 255,290 | 215,187 | 502,596 | 421,467 |
| Cost of revenue | ||||
| Subscription and support | 36,742 | 35,277 | 71,925 | 69,339 |
| Professional services | 13,281 | 14,266 | 26,643 | 28,546 |
| Total cost of revenue | 50,023 | 49,543 | 98,568 | 97,885 |
| Gross profit | 205,267 | 165,644 | 404,028 | 323,582 |
| Operating expenses | ||||
| Research and development | 57,497 | 54,843 | 110,410 | 108,623 |
| Sales and marketing | 109,017 | 104,025 | 213,502 | 205,696 |
| General and administrative | 27,083 | 28,922 | 53,125 | 56,159 |
| Total operating expenses | 193,597 | 187,790 | 377,037 | 370,478 |
| Income (loss) from operations | 11,670 | (22,146) | 26,991 | (46,896) |
| Interest income | 7,712 | 8,344 | 15,815 | 17,091 |
| Interest expense | (3,193) | (3,194) | (6,387) | (6,389) |
| Other income (expense), net | 564 | (736) | 962 | (969) |
| Income (loss) before provision for income taxes | 16,753 | (17,732) | 37,381 | (37,163) |
| Provision for income taxes | 3,311 | 1,668 | 4,943 | 3,608 |
| Net income (loss) | 13,442 | (19,400) | 32,438 | (40,771) |
| Net income (loss) per common share | ||||
| Basic | 0.24 | (0.35) | 0.59 | (0.73) |
| Diluted | 0.24 | (0.35) | 0.58 | (0.73) |
| Weighted-average common shares outstanding | ||||
| Basic | 55,638,926 | 56,076,723 | 55,259,608 | 56,133,286 |
| Diluted | 56,056,066 | 56,076,723 | 55,819,175 | 56,133,286 |
Condensed Consolidated Balance Sheets
(in thousands, except share and per share amounts)
| Description | As of June 30, 2026 (unaudited) | As of December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | 252,482 | 338,769 |
| Marketable securities | 562,760 | 552,852 |
| Accounts receivable, net of allowance for credit losses of $838 and $1,043 at June 30, 2026 and December 31, 2025, respectively | 147,511 | 168,984 |
| Deferred costs | 64,595 | 62,619 |
| Other receivables | 9,892 | 10,383 |
| Prepaid expenses and other | 26,733 | 28,778 |
| Total current assets | 1,063,973 | 1,162,385 |
| Property and equipment, net | 18,970 | 20,546 |
| Operating lease right-of-use assets | 9,700 | 13,986 |
| Deferred costs, non-current | 51,045 | 59,767 |
| Goodwill | 203,599 | 206,164 |
| Intangible assets, net | 19,846 | 22,270 |
| Other assets | 7,318 | 8,453 |
| Total assets | 1,374,451 | 1,493,571 |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||
| Current liabilities | ||
| Accounts payable | 11,778 | 8,932 |
| Accrued expenses and other current liabilities | 105,063 | 113,115 |
| Deferred revenue | 533,867 | 547,919 |
| Convertible senior notes, current | 71,208 | 71,072 |
| Finance lease obligations | 631 | 614 |
| Total current liabilities | 722,547 | 741,652 |
| Convertible senior notes, non-current | 697,352 | 696,263 |
| Deferred revenue, non-current | 32,429 | 37,305 |
| Other long-term liabilities | 101 | 92 |
| Operating lease liabilities, non-current | 6,195 | 10,472 |
| Finance lease obligations, non-current | 12,903 | 13,223 |
| Total liabilities | 1,471,527 | 1,499,007 |
| Stockholders’ deficit | ||
| Class A common stock, $0.001 par value per share, 1,000,000,000 shares authorized, 50,521,260 and 52,712,836 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 51 | 53 |
| Class B common stock, $0.001 par value per share, 500,000,000 shares authorized, 3,569,583 and 3,607,583 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 4 | 4 |
| Preferred stock, $0.001 par value per share, 100,000,000 shares authorized, no shares issued and outstanding | — | — |
| Additional paid-in-capital | 603,995 | 720,923 |
| Accumulated deficit | (701,414) | (733,852) |
| Accumulated other comprehensive income | 288 | 7,436 |
| Total stockholders’ deficit | (97,076) | (5,436) |
| Total liabilities and stockholders’ deficit | 1,374,451 | 1,493,571 |
Condensed Consolidated Statements of Cash Flows
(in thousands)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Cash flows from operating activities | ||||
| Net income (loss) | 13,442 | (19,400) | 32,438 | (40,771) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities | ||||
| Depreciation and amortization | 2,925 | 2,949 | 5,441 | 5,842 |
| Stock-based compensation expense | 29,751 | 28,467 | 58,358 | 56,355 |
| Recovery of doubtful accounts | (82) | (357) | (200) | (345) |
| Accretion of premiums and discounts on marketable securities, net | (741) | (1,390) | (1,542) | (3,085) |
| Amortization of debt discount and issuance costs | 613 | 611 | 1,225 | 1,221 |
| Gain on lease modification | — | — | (307) | — |
| Deferred income tax | 7 | (13) | (262) | (77) |
| Changes in assets and liabilities: | ||||
| Accounts receivable | (9,650) | (504) | 20,506 | 30,132 |
| Deferred costs | 2,928 | (12) | 5,806 | 4,081 |
| Operating lease right-of-use assets | 1,200 | 1,377 | 2,460 | 2,706 |
| Other receivables | (1,995) | (59) | 444 | 935 |
| Prepaid expenses and other | 7,202 | 3,191 | 1,981 | (2,462) |
| Other assets | (144) | 1,386 | 1,089 | 738 |
| Accounts payable | 1,233 | (3,755) | 3,204 | 2,896 |
| Deferred revenue | 18,086 | 15,424 | (15,169) | (3,014) |
| Operating lease liabilities | (989) | (1,087) | (2,156) | (1,918) |
| Accrued expenses and other liabilities | 14,522 | 23,483 | (8,532) | (10,281) |
| Net cash provided by operating activities | 78,308 | 50,311 | 104,784 | 42,953 |
| Cash flows from investing activities | ||||
| Purchase of property and equipment | (332) | (995) | (1,060) | (1,758) |
| Purchase of marketable securities | (123,315) | (102,985) | (214,816) | (205,950) |
| Maturities of marketable securities | 89,370 | 99,738 | 203,720 | 194,352 |
| Acquisitions, net of cash acquired | — | — | (750) | — |
| Purchase of intangible assets | (24) | (41) | (50) | (60) |
| Net cash used in investing activities | (34,301) | (4,283) | (12,956) | (13,416) |
| Cash flows from financing activities | ||||
| Proceeds from option exercises | 322 | 1,803 | 1,051 | 2,434 |
| Taxes paid related to net share settlements of stock-based compensation awards | (1,984) | (569) | (10,646) | (13,491) |
| Proceeds from shares issued in connection with employee stock purchase plan | — | — | 8,052 | 7,535 |
| Repurchases of Class A common stock | (122,684) | (10,002) | (172,684) | (50,120) |
| Principal payments on finance lease obligations | (152) | (139) | (302) | (277) |
| Net cash used in financing activities | (124,498) | (8,907) | (174,529) | (53,919) |
| Effect of foreign exchange rates on cash | (1,287) | 5,108 | (3,586) | 6,997 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | (81,778) | 42,229 | (86,287) | (17,385) |
| Cash, cash equivalents, and restricted cash at beginning of period | 334,972 | 242,736 | 339,481 | 302,350 |
| Cash, cash equivalents, and restricted cash at end of period | 253,194 | 284,965 | 253,194 | 284,965 |
| Supplemental cash flow disclosure | ||||
| Cash paid for interest | 186 | 189 | 5,162 | 5,168 |
| Cash paid for income taxes, net of refunds | 3,839 | 2,481 | 5,762 | 5,510 |
| Noncash investing and financing activities | ||||
| Purchases of property and equipment, accrued but not paid | 282 | — | 282 | — |
| Share repurchase excise tax, accrued but not paid | 1,061 | — | 1,061 | — |
| Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets | ||||
| Cash and cash equivalents at end of period | 252,482 | 284,253 | 252,482 | 284,253 |
| Restricted cash included within prepaid expenses and other at end of period | 712 | 712 | 712 | 712 |
| Total cash, cash equivalents, and restricted cash at end of period shown in the consolidated statements of cash flows | 253,194 | 284,965 | 253,194 | 284,965 |
Amounts as printed on the EDGAR/iXBRL face — (in thousands, except share and per share amounts); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗